Corvus Pharmaceuticals Inc

NEW
FRA:C17 (USA)  
€ 12.2 +0.33 (+2.78%) Sep 4
At Loss
P/B:
5.36
Market Cap:
€ 1.04B ($ 1.21B)
Enterprise V:
€ 856.57M ($ 995.55M)
Volume:
0
Avg Vol (2M):
115.00
Trade In:

Corvus Pharmaceuticals Inc Valuation Measures